Cargando…

Severe COVID-19 Illness and α1-Antitrypsin Deficiency: COVID-AATD Study

Background: Epidemiologic studies have reported that the geographical distribution of the prevalence of allelic variants of serine protein inhibitor-A1 (SERPINA1) and severe cases of COVID-19 were similar. Methods: A multicenter, cross-sectional, observational study to evaluate the frequency of alph...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rodríguez Hermosa, Juan Luis, Vargas Centanaro, Gianna, González Castro, María Estela, Miravitlles, Marc, Lázaro-Asegurado, Lourdes, Jiménez-Rodríguez, Beatriz María, Rodríguez, Rosanel Amaro, Moreno Méndez, Rosaly, Torres-Duran, María, Hernández-Pérez, José María, Humanes-Navarro, Ana María, Calle Rubio, Myriam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9953718/ https://www.ncbi.nlm.nih.gov/pubmed/36831051 http://dx.doi.org/10.3390/biomedicines11020516

Ejemplares similares

Testing for Vitamin D in High-Risk COPD in Outpatient Clinics in Spain: A Cross-Sectional Analysis of the VITADEPOC Study
por: Calle Rubio, Myriam, et al.
Publicado: (2022)

Recommendations for the Implementation of the Self-Administration of Alpha-1 Antitrypsin
por: Torres-Durán, María, et al.
Publicado: (2023)

Utility of Transient Elastography for the Screening of Liver Disease in Patients with Alpha1-Antitrypsin Deficiency
por: Pons, Mònica, et al.
Publicado: (2021)

AATD
por: Hood, E
Publicado: (2002)

COVID-19’s impact on care practice for alpha-1-antitrypsin deficiency patients
por: Calle Rubio, Myriam, et al.
Publicado: (2023)

Using antisense technology to develop a novel therapy for α-1 antitrypsin deficient (AATD) liver disease and to model AATD lung disease
por: Guo, Shuling, et al.
Publicado: (2014)

Long-term Outcomes and Recovery of Patients who Survived COVID-19: LUNG INJURY COVID-19 Study
por: Vargas Centanaro, Gianna, et al.
Publicado: (2022)

Recurrence of emphysema post-lung transplantation in a patient with alpha 1 antitrypsin deficiency (AATD)
por: Ataya, Ali
Publicado: (2020)

Prevalence of genetic mutations in alpha-1 antitrypsin deficiency (aatd) in patients with chronic obstructive pulmonary disease in Colombia
por: Alí-Munive, Abraham, et al.
Publicado: (2023)

Cardiovascular Risk Associated with Alpha-1 Antitrypsin Deficiency (AATD) Genotypes: A Meta-Analysis with Meta-Regressions
por: Ambrosino, Pasquale, et al.
Publicado: (2023)

Testing for alpha-1 antitrypsin in COPD in outpatient respiratory clinics in Spain: A multilevel, cross-sectional analysis of the EPOCONSUL study
por: Calle Rubio, Myriam, et al.
Publicado: (2018)

Correction: Testing for alpha-1 antitrypsin in COPD in outpatient respiratory clinics in Spain: A multilevel, cross-sectional analysis of the EPOCONSUL study
por: Calle Rubio, Myriam, et al.
Publicado: (2019)

Determinants in the Underdiagnosis of COPD in Spain—CONOCEPOC Study
por: Calle Rubio, Myriam, et al.
Publicado: (2022)

Smoking and COPD Knowledge in the General Spanish Population: A CONOCEPOC Study
por: Rodríguez Hermosa, Juan Luis, et al.
Publicado: (2023)

Demographic and clinical characteristics of patients with α(1)-antitrypsin deficiency genotypes PI*ZZ and PI*SZ in the Spanish registry of EARCO
por: Torres-Durán, María, et al.
Publicado: (2022)

Practice and knowledge about diagnosis and treatment of alpha-1 antitrypsin deficiency in Spain and Portugal
por: Esquinas, Cristina, et al.
Publicado: (2016)

Clinical and functional characteristics of individuals with alpha-1 antitrypsin deficiency: EARCO international registry
por: Miravitlles, Marc, et al.
Publicado: (2022)

Correction: Clinical and functional characteristics of individuals with alpha-1 antitrypsin deficiency: EARCO international registry
por: Miravitlles, Marc, et al.
Publicado: (2023)

Exacerbación de la EPOC
por: Calle Rubio, Myriam, et al.
Publicado: (2010)

NAFLD and AATD Are Two Diseases with Unbalanced Lipid Metabolism: Similarities and Differences
por: Perez-Luz, Sara, et al.
Publicado: (2023)

Update on and future perspectives for the diagnosis of alpha-1 antitrypsin deficiency in Brazil
por: Jardim, José R, et al.
Publicado: (2021)

Comorbidity Associations with AATD Among Commercially Insured and Medicare Beneficiaries with COPD in the US
por: Sandhaus, Robert, et al.
Publicado: (2020)

Alpha-1 antitrypsin deficiency: outstanding questions and future directions
por: Torres-Durán, María, et al.
Publicado: (2018)

Diagnosis of alpha-1 antitrypsin deficiency: a population-based study
por: Barrecheguren, Miriam, et al.
Publicado: (2016)

Estimating the Prevalence of AATD Patients in the UK to Identify Underdiagnosis and Determine the Eligibility for Potential Augmentation Therapy
por: Newnham, Michael, et al.
Publicado: (2023)

Employee Engagement and Wellbeing in Times of COVID-19: A Proposal of the 5Cs Model
por: De-la-Calle-Durán, María-Carmen, et al.
Publicado: (2021)

Application of a diagnostic algorithm for the rare deficient variant Mmalton of alpha-1-antitrypsin deficiency: a new approach
por: Belmonte, Irene, et al.
Publicado: (2016)

Association between circulating alpha-1 antitrypsin polymers and lung and liver disease
por: Núñez, Alexa, et al.
Publicado: (2021)

Is SARS-COV-2 associated with alpha-1 antitrypsin deficiency?
por: Rodríguez-García, Carlota, et al.
Publicado: (2023)

Identification and distribution of COPD phenotypes in clinical practice according to Spanish COPD Guidelines: the FENEPOC study
por: Calle Rubio, Myriam, et al.
Publicado: (2017)

Correction to: Association between circulating alpha-1 antitrypsin polymers and lung and liver disease
por: Núñez, Alexa, et al.
Publicado: (2021)

New variants of alpha-1-antitrypsin: structural simulations and clinical expression
por: Gonzalez, Angel, et al.
Publicado: (2022)

Alpha-1 antitrypsin deficiency severity and the risk of COVID-19: A Portuguese cohort
por: Faria, Nuno, et al.
Publicado: (2021)

Impact of COVID-19 in Patients With Severe Alpha-1 Antitrypsin Deficiency: The IMCA1 Study of the EARCO Clinical Research Collaboration
por: Parr, David G., et al.
Publicado: (2022)

Diagnosis and management of α(1)-antitrypsin deficiency in Europe: an expert survey
por: Horváth, Ildikó, et al.
Publicado: (2019)

Opinions and Attitudes of Pulmonologists About Augmentation Therapy in Patients with Alpha-1 Antitrypsin Deficiency. A Survey of the EARCO Group
por: Greulich, Timm, et al.
Publicado: (2022)

Real world evaluation of a novel lateral flow assay (AlphaKit® QuickScreen) for the detection of alpha-1-antitrypsin deficiency
por: Greulich, Timm, et al.
Publicado: (2018)

Alpha-1 antitrypsin deficiency and risk of lung cancer in never-smokers: a multicentre case–control study
por: Tubío-Pérez, Ramón Antonio, et al.
Publicado: (2022)

Abnormal Alpha-1 Antitrypsin Levels and Other Risk Factors Associated with Lung Function Impairment at 6 and 12 Months after Hospitalization Due to COVID-19: A Cohort Study
por: Jiménez-Rodríguez, Beatriz María, et al.
Publicado: (2022)

Long-term evolution of lung function in individuals with alpha-1 antitrypsin deficiency from the Spanish registry (REDAAT)
por: Esquinas, Cristina, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_88o6t7h2574729n5tef49ccvfj